The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
RNS dates 21st April clearly states first tranch .. that’s all am saying being a rookie.. dyor and GLA.
Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, announces that, following the issuance of the Prospectus on 26th March 2020, and pursuant to the Financing and Settlement Agreement entered into by the Company and European High Growth Opportunities Securitization Fund (the "Investor") (see RNS dated 7th February 2020), pursuant to which the Company issued bonds ("Convertible Bonds") convertible into ordinary shares of £0.00001 each in the Company ("Ordinary Shares") to the investor, the Company has received a notice of exercise from the Investor in respect of the exercise by the Investor of its conversion rights under the Convertible Bonds issued in respect of the first tranche drawn down under the Financing and Settlement Agreement for the aggregate principal amount of £50,000 resulting in the issue to the Investor of 555,555,555 new Ordinary Shares ("Conversion Shares").
This looks like a never ending game .. fund gives us £50k n then takes £200k at least a month from us .. and this could go on for a long time .. easy money for the fund .. the PIs I see suffering here .. if there is any believe in this company by the directors why is there no investments into it I.e take a portion of it .also why keep giving these share away at a heavily discounted price if they believe this company is worth great deal.... RNS have no values in there to give us some idea of the value of the company. We get all this wishy washy RNS saying a lot but nothing ... the only time time I remember a value was mentioned for a contract.. the so called 1m contract about to b signed.. that varnished into thin air .. .. who is behind the fund ?..dyor GLA